Board outcome covers Q3 results, CFO and independent director change

Cfo ResignedKmp ResignedManagement Changes View source PDF Explain this filing

AHCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.4%Reaction day

₹12.68

prior close

₹12.87

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.0%-3.4% vs market

Pharmaceuticals peers, median of 159sector+0.4%-2.9% vs sector

On the reaction day the stock moved 3.4 pts less than Nifty Microcap 250 and 2.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.1

10m

-1.7

15m

-1.7

30m

-2.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.4+1.0-3.4+0.4-2.9

Next day

-3.0+0.5-3.5+0.3-3.3

-3.9-0.0-3.9+0.0-3.9

-4.6-1.5-3.1-1.2-3.4

-4.8-2.2-2.6-1.7-3.1

-3.9-1.2-2.7-1.8-2.2

-7.7-2.4-5.4-2.5-5.2

15d

-14.0-8.8-5.2-6.9-7.1

-1.1-8.3+7.2-5.1+4.0

+2.2-3.5+5.8-3.5+5.7

+12.0+6.4+5.6+2.8+9.2

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 159Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Anlon Healthcare board on Feb 9 approved Q3 FY26 results: revenue Rs 35.58 cr for the quarter, 9M revenue Rs 121.08 cr, 9M profit Rs 18.02 cr, EPS Rs 3.94. CFO Hitesh Makwana resigned for pre-occupation; Naimish Bhatt named new CFO with 18 years finance experience. Independent Director Shailesh Thakkar resigned for health reasons; Kishan Raja, a Chartered Accountant, appointed in his place. IPO proceeds of Rs 121.03 cr have been used as planned with no deviation.

Likely market impact

CFO and board reshuffle with strong 9M profit growth and clean IPO fund use.